In addition,
Sale unit antibiotics arouses contrasting:
The Federal Council wants antibiotics to be sold to the unit in pharmacies. Consequently, The measure, which aims to combat antibiotic resistance and shortages, raises contrasting reactions among players in the sector.
Switzerland is about to transform the distribution of antibiotics. In addition, A bill submitted to consultation must be presented at the end of 2026 by the Federal Council.
The government pursues two major objectives with this measure. However, On the one hand, he seeks to fight against antibiotic resistance, an increasing public health problem. Therefore, On the other hand, it aims to better manage drug shortages, a recurring challenge for the Swiss health system.
By selling antibiotics to the unit. Consequently, the authorities hope that patients will only receive the exact quantity they need for their treatment. This approach could reduce overconsumption or waste.
>> Reread: Antibiotics will have to be given to sale unit antibiotics arouses contrasting the future in Switzerland in the future
Pharmacists open to. experience – Sale unit antibiotics arouses contrasting
Swiss pharmacists are favorable to this proposal. Martine Ruggli, president of Pharma Switzerland, the umbrella association of pharmacists, judges the idea “promising and realistic”. It is based on experiences already carried out in the cantons of Ticino and Neuchâtel.
“This is a completely doable decision. We must have already implemented it in two cantons to try. We did a practicing study,” she said on Friday in the morning of the RTS.
A logistical challenge to be met
The implementation of this system will however require adjustments. Martine Ruggli underlines an increase in the workload: “We have seen an increase in working time for antibiotics. because it is necessary to be sure to have the same charges, and the same lots in case a medication had to be recalled. It is a work that requires about five additional minutes to put the medication,” she said.
The sale unit antibiotics arouses contrasting umbrella Pharma Switzerland, for its part, remains cautious. It requires concrete evidence of the effectiveness of this measure on the reduction of antibiotic resistance.
The skeptical pharmaceutical industry
On the side of pharmaceutical companies, the reception is more mixed. Interpharma, their umbrella association, describes this initiative as “false good idea”. According to her, deconditioning drugs creates risks of contamination, confusion and complicates product reminders.
For Interpharma, the real issue lies in the lack of new antibiotics on the market. The association pleads for the implementation of financial incentives in order to encourage the research and development of new treatments.
Cynthia Racine/asch
Further reading: Trade war review | “The most serious scenarios have not yet materialized” – Nemetschek targets up to $ 2.9 billion for future acquisitions – Flood of requests from the IVZE program in January: Tesla may have its $ 20 million from the federal – How to get your money back if you haven’t closed your account on time – Rents still increasing in June, but not in Geneva.
